Incanthera Regulatory News (INC.PL)

6 October 2025

Incanthera plc

("Incanthera" or the "Company")

INVESTOR PRESENTATION

PROACTIVE BIOTECH ONE2ONE INVESTOR FORUM

9 OCTOBER 2025

Incanthera plc (AQSE:INC), the company specially focussed on innovative technologies in dermatology and oncology, announces that it will be presenting at the Proactive Investor Forum in London at 6.00 p.m. on Thursday 9 October 2025 to an audience of high net worth investors, fund managers, private client brokers and analysts.

Incanthera will be delivering a presentation, which will not contain any inside information, and will be made available on its website, www.incanthera.com.

In order to register for the event, please use the attached link: Proactive One2One Investor Forum - Thursday 9th October Tickets, Thu 9 Oct 2025 at 18:00 | Eventbrite

RNS Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature.

For further information please contact:

Incanthera plc:

Notes to Editors

Incanthera is a specialist company focused on innovative technologies in dermatology and oncology. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading specialists and academic institutions as well as its in-house development team.

The Company originated from the Institute of Cancer Therapeutics ("ICT") at the University of Bradford. Incanthera's strategy is to develop each candidate in its portfolio from initial acquisition or discovery to securing its future through commercially valuable partnerships at the earliest opportunity in its development pathway.

For more information on the Company please visit: www.incanthera.com

@incantheraplc